MedTrace Logo

Monocentric Retrospective Observational Study on Patients With Macular Degeneration

NCT02089503 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2014-03-18

No results posted yet for this study

Summary

Main Objective: The main objective of this retrospective observational study was to describe the evolution of visual acuity measured on ETDRS (Early Treatment Diabetic Retinopathy Study) scale, for patients with exudative Age-Related Macular Degeneration (ARMD), treated with Lucentis, under real conditions of care, in terms of mean change of the Best Corrected Visual Acuity (BCVA), measured at 24 months (± 4 weeks).

Conditions

  • Exudative Age-Related Macular Degeneration

Interventions

OTHER

intravitreal injections of Lucentis

intravitreal injections FOR ALL PATIENTS of Lucentis as required in the normal condition of use

Sponsors & Collaborators

  • Hospital St. Joseph, Marseille, France

    lead OTHER

Principal Investigators

  • Maud RIGHINI, MD · HSJ

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2014-05-31
Completion
2014-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02089503 on ClinicalTrials.gov